Back to top
more

Bausch Health Cos Inc. (BHC)

(Real Time Quote from BATS)

$17.90 USD

17.90
2,374,129

-0.75 (-4.02%)

Updated Jul 16, 2020 12:56 PM ET

Add to portfolio

4-Sell of 5       4  

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.04%
17.51%
9.10%
4.64%
1.64%
10.44%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

A Value C Growth F Momentum B VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Bausch (BHC) Up 21.2% Since Last Earnings Report: Can It Continue?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BHC

Zacks Equity Research

Bausch (BHC) Down on Q1 Earnings & Sales Miss, View Trimmed

Bausch (BHC) misses on earnings and sales in the first quarter and lowers guidance due to the coronavirus pandemic.

ENDP NVS MNK BHC

Zacks Equity Research

Endo (ENDP) Q1 Earnings Beat on Coronavirus-Led Stockpiling

Endo's (ENDP) earnings and sales beat estimates in the first quarter owing to increased customer inventory purchasing due to the COVID-19 pandemic

ENDP INFI MNK BHC

Zacks Equity Research

Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates

Bausch (BHC) delivered earnings and revenue surprises of -1.11% and -1.68%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

BHC

Zacks Equity Research

Should You Buy Bausch Health (BHC) Ahead of Earnings?

Bausch Health (BHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BHC

Zacks Equity Research

Bausch Health (BHC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Bausch (BHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BHC

Zacks Equity Research

Karyopharm Starts Dosing With Selinexor for Coronavirus Infection

Karyopharm (KPTI) doses the first patient in a phase II study evaluating the low dose of its drug Xpovio (selinexor) to treat hospitalized patients with severe COVID-19 infection. Shares up.

SNY RHHBY KPTI BHC

Zacks Equity Research

Bausch (BHC) Starts Study on Virazole for Coronavirus Infection

Bausch (BHC) begins a clinical study on Virazole in combination with standard-of-care therapy to treat adults with respiratory distress due to COVID-19 in Canada.

RHHBY INCY NVS BHC

Zacks Equity Research

Aerie (AERI) Suspends Guidance Due to Coronavirus Outbreak

Aerie (AERI) suspends annual guidance as volumes get impacted due to the COVID-19 outbreak.

PFE AGN AERI BHC

Zacks Equity Research

Why Is Bausch (BHC) Down 46.5% Since Last Earnings Report?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BHC

Zacks Equity Research

Aerie's (AERI) Q4 Loss Wider Than Expected, Revenues Beat

Aerie (AERI) reports a wider loss in the fourth quarter, while sales surpass expectations.

PFE AGN AERI BHC

Zacks Equity Research

Bausch's (BHC) Q4 Earnings Match Estimates, Revenues Miss

Bausch (BHC) reports mixed fourth-quarter results, with earnings meeting expectations but sales missing the same.

UTHR PCRX XNCR BHC

Zacks Equity Research

Should You Buy Bausch Health (BHC) Ahead of Earnings?

Bausch Health (BHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BHC

Zacks Equity Research

Should Value Investors Pick Bausch Health (BHC) Stock Now?

Is Bausch Health (BHC) a great pick from the value investor's perspective right now? Read on to know more.

BHC

Zacks Equity Research

Aerie's (AERI) Application for Roclanda Accepted in Europe

European authorities accept Aerie's (AERI) filing for its second ophthalmology drug, Roclanda.

AGN PFE AERI BHC

Zacks Equity Research

5 Reasons Why Ironwood Stock Should Be in Your Portfolio

We provide five reasons which makes Ironwood (IRWD) a good investment option in 2020.

AZN AGN IRWD BHC

Zacks Equity Research

Bausch's (BHC) Arazlo Gets FDA Approval for Acne Vulgaris

Bausch (BHC) gets FDA approval for Arazlo Lotion for the topical treatment of acne vulgaris in patients nine years of age or older.

ALKS INVA ANIK BHC

Zacks Equity Research

Top Ranked Value Stocks to Buy for December 13

Here are four stocks with buy rank and strong value characteristics for investors to consider today, December 13th

ODP NMM BHC AEL

Zacks Equity Research

Are You Looking for a Top Momentum Pick? Why Bausch Health (BHC) is a Great Choice

Does Bausch Health (BHC) have what it takes to be a top stock pick for momentum investors? Let's find out.

BHC

Zacks Equity Research

Is Bausch Health (BHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

BHC

Zacks Equity Research

Why Is Bausch (BHC) Up 8.2% Since Last Earnings Report?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BHC

Zacks Equity Research

Why Bausch (BHC) Might be Well Poised for a Surge

Bausch (BHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

BHC

Zacks Equity Research

Moving Average Crossover Alert: Bausch Health Companies

Bausch Health Companies is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

BHC

Indrajit Bandyopadhyay

Generic Drugmakers Gain as Price-Fixing Probe Nears an End

Shares of generic drugmakers rose on Monday on a possible end to the persistent price-fixing probe.

TEVA AKRX ZYNE BHC

Zacks Equity Research

Top Ranked Value Stocks to Buy for November 26th

Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 26th

HA EQH DAC BHC